The Colon Cancer Challenge Foundation is a 501(c)3 non-profit organization registered in New York State and listed by the Federal IRS as a public charity dedicated to reducing colorectal cancer incidence and death. Our mission includes: supporting research into the causes and cures for colorectal cancer; increasing public awareness; educating the public about the importance of early detection; and forming strategic partnerships in the fight against colorectal cancer.
Over 150,000 new cases of colon cancer will be diagnosed in the United States this year and 50,000 people will die. The good news is that with early screening, colon cancer is preventable, treatable and beatable. Your tax-deductible donation and/or involvement with the Colon Cancer Challenge Foundation help us further our mission to support colon cancer prevention through research, screening and public awareness.
A major area of interest for CCCF is research including the understanding of the causes for early age of onset and hereditary colorectal cancer. A key component of the research agenda is to facilitate the pairing of young investigators with well established doctors at leading academic medical centers and research institutions in an effort to encourage young investigators to focus their academic careers on better understanding colorectal cancer to increase prevention, early detection and improved treatments. This agenda will be advanced by competitive awards to young investigators and/or mentors through dedicated academic research societies.
Screening & Public Awareness
In order to promote public awareness of colorectal cancer and the importance of early detection, the CCCF sponsors events such as, but not limited to, the New York Colon Cancer Challenge held in collaboration with New York Road Runners each March during National Colorectal Cancer Awareness Month in Central Park.
The CCCF hopes to further its mission through sponsorship of additional events, including walks/runs in other major cities, and partnering with and supporting strategic partners in the fight against colorectal cancer.